The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4...
Join us in 2021 for our signature 2021 STAT Summit. As we gather the top minds in the life sciences, we’ll deliver live the best of what STAT reporters do year-in, year-out: analysis and discussion around the most important topics in biotech, medicine, and policy brought to life by the industry’s top talent. As a bonus,...
Join the Biocom California Tech+Biotech+Medtech community as we explore the current and future state of cyber security. What strategies do life science companies need to implement to make sure your company data, research data, and clinical data is safe? Our panel will address the cyber security needs of the life science community, how companies can...
Delivered as a Hybrid Event November 17-23, 2021 In-Person November 17-19 | Virtual November 22-23, Philadelphia, PA PHARMA & BIOTECH BEST PRACTICES FOR GTN MANAGEMENT, EFFECTIVE FORECASTS, ENHANCED VISIBILITY, PROFITABILITY AND CONTROL The foremost and longest-standing event for model-sharing on strategic forecasting, estimates, analytics and reporting for life science companies. ANNOUNCING GTN AS A HYBRID...
The RARE Health Equity Summit was developed in order to gain a better understanding of persistent gaps in diagnostic challenges for underserved/underrepresented patient communities and align next steps on how to address health inequities of the rare disease community. This event connects stakeholders from the rare disease community, including our RARE Health Equity Leadership Council, to...
8:30-13:30 Pacific Time, Free online symposium via Zoom by PBSS-SF Bay on artificial intelligence and machine learning Speakers: Abraham Heifets (Atomwise); Tom Miller (Entos AI); Fio Ruggiu (Insitro); Wayne Tang & Sathesh Bhat (Schrodinger); Alex Zhavoronkov (Insilico); Vijay Shahani (Cyclica); Brandon Allgood (Valo Health)
Going public is a unique, intense and critically important journey for life science companies, and there’s a wealth of knowledge to gain from industry peers who’ve been there before. Nasdaq and Danforth Advisors invite you to join a virtual conversation about one company’s journey; Gemini Therapeutics, which became public following a $216M SPAC transaction this...
Brent will share insights from his role as the Chief Business Officer and US General Manager of OncoOne, the world’s experts in developing therapies targeting the macrophage migration inhibitory factor, or MIF, for patients with solid tumors and severe inflammatory conditions. Brent Meadows has over 25 years of US and Global commercial strategy, launch marketing,...
You have managed to lead your finance organization through multiple rounds of private funding. You have supported your executives as they navigate the harrowing path of bringing a drug candidate out of the lab and into clinical trials. Now you are looking at raising capital in the public markets to continue to support that growth....
Groundbreakers. Leaders. Advocates. The rare disease community is full of people who inspire us all through innovation, research, compassion and a relentless spirit to affect positive change. Through the RARE Champions of Hope Awards, we honor and recognize true champions for rare disease. This year we will be recognizing leaders who have made a significant impact...
8 STREAMS | 1000+ Delegates | 200+ Speakers ✓ Antibody Engineering & Therapeutics ✓ Inhalation & Respiratory Drug Delivery ✓ Pharmacovigilance & Drug Safety ✓ Pre-filled Syringes & Injectables ✓ Gut-Brain Axis ✓ Probiotics, Human & Skin Microbiome ✓ Aseptic Processing Technology ✓ CDx/Biomarkers & Biobanking The BioTech Pharma Summit will bring together the movers...
Hosted virtually by Sheila Gwizdak, VP of Quality and Organizational Solutions, and a Panel of Halloran Quality Experts The FDA recently published a bioresearch monitoring (BIMO) update to their compliance program governing inspections for sponsors and CROs. Let’s unpack these updates together. In this Speaker Series, prepare to hear about the new sub-sections in the...
